Nova Global Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.00 M
as on 24-10-2024
- Satisfied Charges ₹ 9.30 M
as on 24-10-2024
- Revenue 67.78%
(FY 2023)
- Profit 87.75%
(FY 2023)
- Ebitda 26.23%
(FY 2023)
- Net Worth 75.97%
(FY 2023)
- Total Assets 14.91%
(FY 2023)
About Nova Global Medicare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.10 Cr. The company has closed loans amounting to ₹9.30 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Shetty and Chandana Shetty serve as directors at the Company.
- CIN/LLPIN
U24233PN2015PTC154157
- Company No.
154157
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nova Global Medicare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Shetty  | Director | 02-Mar-2015 | Current |
| Chandana Shetty | Director | 02-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Nova Global Medicare.
Nova Global Medicare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.78% increase. The company also saw a substantial improvement in profitability, with a 87.75% increase in profit. The company's net worth Soared by an impressive increase of 75.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nova Global Medicare?
In 2023, Nova Global Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 May 2024 | ₹1.10 Cr | Open |
Yes Bank Limited Creation Date: 29 May 2023 | ₹1.00 Cr | Open |
Others Creation Date: 16 Dec 2019 | ₹4.00 M | Satisfied |
How Many Employees Work at Nova Global Medicare?
Nova Global Medicare has a workforce of 12 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nova Global Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Global Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
